Metastatic Cancer Treatment Market Trends
The increasing patient pool for cancer as well as the rising geriatric population and life expectancy are expected to be the major factors for the growth of the market. Pharmaceutical giants such as Roche and Novartis are investing in the R&D for the development of innovative and improved medication for the treatment of the disease. Rising interest in the biologics medication especially monoclonal antibodies is also expected to fuel the growth of the market.
The increasing patient pool for cancer as well as the rising geriatric population and life expectancy are expected to be the major factors for the growth of the market. Pharmaceutical giants such as Roche and Novartis are investing in the R&D for the development of innovative and improved medication for the treatment of the disease. Rising interest in the biologics medication especially monoclonal antibodies is also expected to fuel the growth of the market.
- TAGS
- healthcare-industry
- healtcareit
- healtcare
- news
- bisresearch
- lung-cancer-drugs-market
- lung-cancer-market
- colorectal-cancer-market
- prostate-cancer-market
- melanoma-market
- melanoma-treatment-market
- oncology-drugs-market
- cancer-treatment-market
- oncology-market
- breast-cancer-market
- metastasis-cancer-market
- metastatic-cancer-market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
The following figure exhibits key secondary data sources considered in this report:<br />
Figure 2<br />
Secondary Data Sources<br />
STOCK ANALYST WEBSITES<br />
COMPANY SOURCES<br />
Seeking Alpha<br />
Yahoo Finance<br />
Wiki Finance<br />
The Wall Street Journal<br />
Annual Reports<br />
Press Releases<br />
Sec Filings<br />
Investor Presentations<br />
Financial Disclosures<br />
SECONDARY DATA SOURCES<br />
GOVERNMENT AND REGULATORY SOURCES<br />
Centers for Disease Control and Prevention (CDC)<br />
The World Health Organisation (WHO)<br />
The National Health Services (NHS)<br />
The National Center for Biotechnology Infromation (NCBI)<br />
The Food & Drug Administration of United States (U.S. FDA)<br />
PUBLIC AND PRIVATE DATABASES<br />
Medline<br />
PubMed<br />
National Library of Medicine<br />
ProQuest<br />
CMS Database<br />
Medicare Beneficiary Database<br />
Oxon Epidemiology<br />
BIS Research Analysis<br />
The key data points taken from the secondary sources include:<br />
• Segmentation breakups, split-ups, and percentage shares<br />
• Data for market value<br />
• Key industry trends of the top players of the market<br />
• Qualitative insights into various aspects of the market, key trends, and emerging areas of<br />
innovation<br />
• Quantitative data for mathematical and statistical calculations<br />
sales@bisresearch.com www.bisresearch.com 10
Change language